NRX Pharmaceuticals vs Ovid Therapeutics
NRXP and OVID side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NRXP and OVID compare
Ovid Therapeutics is the larger company, worth 5.0 times as much as NRX Pharmaceuticals ($469M against $93.1M).
NRX Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −692% compared with −2179% at Ovid Therapeutics.
Ovid Therapeutics scores higher on the StockData Score (9 against 0 for NRX Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NRXP | OVID |
|---|---|---|
| Size and price | ||
| Market cap | $93.1M | $469M |
| Share price | $2.15 | $2.40 |
| Change, 1 year | −17.0% | 100% |
| Change, 5 years | −96.8% | −26.4% |
| Beta (5Y) | 1.35 | 1.24 |
| Employees | 29 | 23 |
| StockData Score | ||
| Total score | 0 | 9 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 0 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 27.4× (better) | 296× |
| P/B | – | 2.2× |
| Growth | ||
| Revenue growth (TTM) | – | −76.2% |
| Revenue growth, 5Y average | – | −10.5% |
| Profitability | ||
| Gross margin | 46.6% | – |
| Operating margin | −586% (better) | −3687% |
| Net margin | −692% (better) | −2179% |
| Return on equity | – | −26.0% |
| Return on invested capital | – | −160% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −17.4× | – |
| Current ratio | 0.86 | 12.39 (better) |
| Altman Z-score | −13.67 | 10.36 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 26.9% | 75.3% |
| Held by insiders | 15.6% | 13.6% |
| Insider net buying, 12 months | – | −$29.3K |
| Short interest, % of float | 28.6% | 10.8% |
Go deeper
- NRXP stock overview
- NRXP income statement
- NRXP valuation and score
- OVID stock overview
- OVID income statement
- OVID valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.